Last reviewed · How we verify
dl-alpha-tocopherol
dl-alpha-tocopherol acts as an antioxidant by scavenging free radicals and protecting cells from oxidative damage.
dl-alpha-tocopherol acts as an antioxidant by scavenging free radicals and protecting cells from oxidative damage. Used for Prevention of vitamin E deficiency, Treatment of erythropoietic protoporphyria.
At a glance
| Generic name | dl-alpha-tocopherol |
|---|---|
| Also known as | Vitamin E |
| Sponsor | US Department of Veterans Affairs |
| Drug class | Vitamin E derivative |
| Modality | Small molecule |
| Therapeutic area | Oncology, Neurology |
| Phase | Phase 3 |
Mechanism of action
dl-alpha-tocopherol, a form of vitamin E, has been shown to have anti-inflammatory properties and protect against cell damage caused by free radicals. This antioxidant activity is thought to contribute to its potential therapeutic benefits.
Approved indications
- Prevention of vitamin E deficiency
- Treatment of erythropoietic protoporphyria
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Effect of PEA on Muscle Recovery Following Resistance Exercise (NA)
- Vitamin E Efficacy in HI/HA (PHASE2)
- A Study to Evaluate the Effect of Astaxanthin in Healthy Participants (NA)
- Vitamin B Complex Improved Exercise Performance and Anti-fatigue (NA)
- Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients (PHASE2)
- Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy (PHASE3)
- Vitamin E Supplementation in Burn Patients (PHASE1)
- 2017 A/H7N9 IIV Revaccination (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dl-alpha-tocopherol CI brief — competitive landscape report
- dl-alpha-tocopherol updates RSS · CI watch RSS
- US Department of Veterans Affairs portfolio CI